Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Loans
    HomeNewsMarksanspharma

    Jump to
    • Buy Mankind Pharma; target of Rs 2990: Motilal Oswal

      Buy Mankind Pharma; target of Rs 2990: Motilal Oswal

      Motilal Oswal is bullish on Mankind Pharma has recommended buy rating on the stock with a target price of Rs 2990 in its research report dated August 01, 2025.

    • Buy Mankind Pharma; target of Rs 2910: Motilal Oswal

      Buy Mankind Pharma; target of Rs 2910: Motilal Oswal

      Motilal Oswal is bullish on Mankind Pharma recommended buy rating on the stock with a target price of Rs 2910 in its research report dated May 22, 2025.

    • Buy Mankind Pharma; target of Rs 3050: Motilal Oswal

      Buy Mankind Pharma; target of Rs 3050: Motilal Oswal

      Motilal Oswal is bullish on Mankind Pharma has recommended buy rating on the stock with a target price of Rs 3050 in its research report dated January 25, 2025.

    • Buy Mankind Pharma; target of Rs 3140: Motilal Oswal

      Buy Mankind Pharma; target of Rs 3140: Motilal Oswal

      Motilal Oswal is bullish on Mankind Pharma has recommended buy rating on the stock with a target price of Rs 3140 in its research report dated November 05, 2024.

    • Buy Mankind Pharma; target of Rs 2760: Motilal Oswal

      Buy Mankind Pharma; target of Rs 2760: Motilal Oswal

      Motilal Oswal is bullish on Mankind Pharma recommended buy rating on the stock with a target price of Rs 2760 in its research report dated August 23, 2024

    • Buy Mankind Pharma; target of Rs 2650: Motilal Oswal

      Buy Mankind Pharma; target of Rs 2650: Motilal Oswal

      Motilal Oswal is bullish on Mankind Pharma has recommended buy rating on the stock with a target price of Rs 2650 in its research report dated July 26, 2024.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347